Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

NCT05415345 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papilloma Virus Infection Type 16
Human Papilloma Virus Infection Type 18
Hepatitis E Virus Infection

Interventions

BIOLOGICAL: Cecolin
BIOLOGICAL: Hecolin

Sponsor

Xiamen Innovax Biotech Co., Ltd

Collaborators

[object Object]